Skip to main content
Log in

Effect of neuroleptics on positive and negative symptoms and the deficit state

  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The concept of negative symptoms tries to operationalize a deficit syndrome observed in schizophrenia, but also in other disorders. The instruments for the measurement developed so far are unclear in their dimensional structure and validity. Further methodological development is needed. A new scale for measuring negative symptoms was derived from the AMDP-system and applied to results of drug trials with clozapine, fluperlapine, and haloperidol. The three drugs were equally effective on negative symptoms of acute and chronic schizophrenics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Andreasen NC (1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39:784–788

    Google Scholar 

  • Andreasen NC, Olsen S (1982) Negative versus positive schizophrenia: definition and validation. Arch Gen Psychiatry 39:789–794

    Google Scholar 

  • Angst J, Dinkelkamp T (1974) Die somatische Therapie der Schizophrenie. Literature der Jahre 1966–1972 (Sammlung psychiatrischer und neurologischer Einzeldarstellungen). Thieme, Sluttgart

    Google Scholar 

  • Angst J, Woggon B (1983) Validity of the AMP-system for its use in clinical psychopharmacology. In: Bobon D, Baumann U, Angst J, Helmchen H, Hippius H (eds) The AMDP-system in pharmacopsychiatry (Modern problems of pharmacopsychiatry, vol 20). Karger, Basel, pp 174–184

    Google Scholar 

  • Ban TA, Guy W, Wilson WH (1985) The AMDP-system in chronic hospitalized schizophrenics. Compr Psychiatry 26:370–374

    Google Scholar 

  • Barnes TR, Braude WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 42:874–878

    Google Scholar 

  • Bleuler E (1911) Dementia praecox oder Gruppe der Schizophrenien. In: Aschaffenburg G (Hrsg) Handbuch der Psychiatrie, spez. Teil 4/I. Deuticke, Leipzig Wien, S 1–420

    Google Scholar 

  • Bleuler M (1972) Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken- und Familiengeschichten. Thieme, Stuttgart

    Google Scholar 

  • Carpenter WT, Jr, Heinrichs DW, Alphs LD (1985) Treatment of negative symptoms. Schizophr Bull 11:440–452

    Google Scholar 

  • Ciompi L, Lai GP (1969) Dépression et vieillesse. Etudes catamnestiques sur le vieillissement et la mortalité de 555 ancien patients dépressifs. Huber, Bern

    Google Scholar 

  • Ciompi L, Müller C (1976) Lebensweg und Alter der Schizophrenen. Eine katamnestische Langzeitstudie bis ins Senium. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Conrad K (1958) Die Beginnende Schizophrenie. Versuch einer Gestaltanalyse des Wahns. Thieme, Stuttgart

    Google Scholar 

  • Crow TJ (1985) The two-syndrome concept: origins and current status. Schizophr Bull 11:471–486

    Google Scholar 

  • Csesernansky JG, Kaplan J, Holman CA, Hollister LE (1983) Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients. Psychopharmacology 81:115–118

    Google Scholar 

  • Ernst K (1962) Neurotische und endogene Residualzustände. Arch Psychiatr Neurol 203:61–84

    Google Scholar 

  • Gibbons RD, Lewine RRJ, Davis JM, Schooler NR, Cole JO (1985) An empirical test of a Kraepelinian versus a Bleulerian view of negative symptoms. Schizophr Bull 11:390–396

    Google Scholar 

  • Glatzel J (1967) Zur Frage der schizophrenen Verläufe unter der Pharmakotherapie. Arch Psychiatr Nervenkr 209:87–100

    Google Scholar 

  • Goffman E (1961) Asylums. Anchor Books, New York

    Google Scholar 

  • Goldberg SC (1985) Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull 11:453–456

    Google Scholar 

  • Good I (1988) Sogenannte Minussymptome bei chronischer Schizophrenie. Interrater-Reliabilitäts-Untersuchung an zwei Negativsymptom-Skalen (SANS, NSRS). Med. Dissertation, Zürich (in Vorberitung)

  • Grau BW, Mueser KT (1986) Measurement of negative symptoms. Schizophr Bull 12:7–8

    Google Scholar 

  • Heinrich K (1967) Zur Bedeutung des postremissiven Erschöpfungs-Syndroms für die Rehabilitation Schizophrener. Nervenarzt 38:487–491

    Google Scholar 

  • Hirsch SR, Knights A (1982) Gibt es die pharmakogene Depression wirklich? Beweismaterial aus zwei prospektiven Untersuchungen. In: Kryspin-Exner K, Hinterhuber H, Schubert H (Hrsg) Ergebnisse der psychiatrischen Therapieforschung. Schattauer, Stuttgart New York, S 249–268

    Google Scholar 

  • Hoffman WF, Labs SM, Casey DE (1987) Neuroleptic-induced Parkinsonism in older schizophrenics. Biol Psychiatry 22:427–439

    Google Scholar 

  • Huber G (1957) Pneumencephalographische und psychopathologische Bilder bei endogenen Psychosen. Springer, Berlin Göttingen Heidelberg

    Google Scholar 

  • Huber G, Gross G, Schüttler R (1979) Schizophrenie. Verlaufs-und sozialpsychiatrische Langzeituntersuchungen an den 1945–1959 in Bonn hospitalisierten schizophrenen Kranken. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Iager AC, Kirch DG, Wyatt RJ (1985) A negative symptom rating scale. Psychiatry Res 16:27–36

    Google Scholar 

  • Jackson JH (1884) Evolution and dissolution of the nervous system. In: Taylor J (ed) Selected writings of John Hughlings Jackson, vol 2: various papers, addresses and lectures. Basic Books, New York (1958)

    Google Scholar 

  • Janzarik W (1959) Dynamische Grundkonstellationen in endogenen Psychosen. Ein Beitrag zur Differentialtypologie der Wahnphänomene (Monographien aus dem Gesamtgebiete der Neurologie und Psychiatric, Heft 86). Springer, Berlin Göttingen Heidelberg

    Google Scholar 

  • Kay SR, Opler LA (1987) The positive-negative dimension in schizophrenia: its validity and significance. Psychiatr Dev 5:79–103

    Google Scholar 

  • Koehler K, Sauer H (1984) Huber's basic symptoms: another approach to negative psychopathology in schizophrenia. Compr Psychiatry 25:174–182

    Google Scholar 

  • Lewine RRJ, Fogg L, Meltzer HY (1983) Assessment of negative and positive symptoms in schizophrenia. Schizophr Bull 9:368–376

    Google Scholar 

  • Mayer-Gross W (1920) Ueber die Stellungnahme zur abgelaufenen akuten Psychose. Eine Studie über verständliche Zusammenhänge in der Schizophrenie. Z Gesamte Neurol Psychiatr 60:160–212

    Google Scholar 

  • Meltzer HY, Sommers AA, Luchins DJ (1986) The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. J Clin Pharmacol 6:329–338

    Google Scholar 

  • Möller HJ, Zerssen D von (1981) Depressive Symptomatik bei Aufnahme und Entlassung stationär behandelter schizophrener Patienten. Nervenarzt 52:525–530

    Google Scholar 

  • Möller HJ, Zerssen D von (1986) Der Verlauf schizophrener Psychosen unter den gegenwärtigen Behandlungsbedingungen. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799–812

    Google Scholar 

  • Prosser ES, Csernansky JG, Kaplan J, Thiemann S, Becker TJ, Hollister LE (1987) Depression, Parkinsoniabn symptoms, and negative symptoms in schizophrenics treated with neuroleptics. J Nerv Ment Dis 175:100–105

    Google Scholar 

  • Sommers AA (1985) “Negative symptoms”: conceptual and methodological problems. Schizophr Bull 11:364–379

    Google Scholar 

  • Straumann D (1988) Sogenannte Minussymptome bei chronischer Schizophrenie. Eine psychopathologische Untersuchung an 50 stationären Patienten. Med. Dissertation, Zürich (in Vorbereitung)

  • Strauss J, Carpenter WT Jr, Bartko J (1974) The diagnosis and understanding of schizophrenia: Part III. Speculation on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1/11:61–69

    Google Scholar 

  • Waddington JL, Youssef HA (1986) Late onset involuntary mouvements in chronic schizophrenia: relationship of ‘tardive’ dyskinesia to intellectual impairment and negative symptoms. Br J Psychiatry 149:616–620

    Google Scholar 

  • Waddington JL, Youssef HA, Molloy AG, O'Boyle KM, Pugh MT (1985) Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies. J Clin Psychiatry 46:29–33

    Google Scholar 

  • Waddington JL, Youssef HA, Dolphin C, Kinsella A (1987) Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality. Arch Gen Psychiatry 44:907–912

    Google Scholar 

  • Woggon B, Angst J (1976) Einzelne Aspekte der Behandlung mit depotneuroleptika. In: Huber G (Hrsg). Therapie, Rehabilitation und Prävention schizophrener Erkrankungen. 3. “Weissenauer” Schizophreniesymposion, Lübeck-Travemünde 1975. Schattauer, Stuttgart New York, S 191–200

    Google Scholar 

  • Woggon B, Beckmann H, Heinrich K, Linden M, Krebs E, Küfferle B, Pflug B, Rüther E, Schied HW (1986) Clinically relevant differences in the therapeutic profile of fluperlapine compared to Haloperidol in the treatment of schizophrenic psychosis. Results of a multicentre double-blind study. Pharmacopsychiatria 19:204–205

    Google Scholar 

  • Zubin J (1985)Negative symptoms: are they indigenous to schizophrenia? Schizophr Bull 11:461–470

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angst, J., Stassen, H.H. & Woggon, B. Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology 99 (Suppl 1), S41–S46 (1989). https://doi.org/10.1007/BF00442558

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442558

Key words

Navigation